R. E. Gawley et al. / Tetrahedron: Asymmetry 13 (2002) 29–36
35
1
7.2.3. (1R,2S,6R,7S)-5-((1R,2R)-2-Hydroxy-1-phenyl-
sulfanylbutyl)-1,10,10-trimethyl-3-oxo-5-aza-tricyclo-
[5.2.1.02,6]-decane-4-one 10d (from addition of 3 to
propanal). Mp: 67–69°C; IR (KBr): (br) 3450, 3010,
2990, 1700, 1490, 1410, 1360, 1340, 1270, 1220, 1100,
1360, 1340, 1270, 1220, 1100, 1040, 980, 820 cm−1. H
NMR (400 MHz, CDCl3): l 7.7–7.2 (m, 10H), 5.1 (s,
1H), 4.8 (m, 1H), 3.8 (m, 1H), 2.7–2.2 (m, 3H), 2.1 (m,
2H), 0.90 (s, 3H), 0.77 (s, 3H), 0.68 (s, 3H). 13C NMR
(90 MHz, CDCl3): l 4.0, 5.3, 11.2, 27.7, 29.2, 33.3, 34.6,
38.2, 48.6, 88.2, 92.0, 127.2, 128.8, 129.9, 130.2, 132.4,
134.8, 134.3, 134.8, 179.4, 184.2. ESI-MS calcd for
C25H28NO3S (MH+): 422.1790; found 422.1798. Anal.
calcd for C25H27NO3S: C, 71.23%, H, 6.46%; found: C,
71.16%, H, 6.54%.
1
1030, 970, 930, 820 cm−1. H NMR (400 MHz, CDCl3):
l 7.6–7.2 (m, 5H), 5.1 (d, J=6 Hz, 1H), 4.2 (d, J=6
Hz, 1H), 4.1 (m, 1H), 3.9 (m, 2H), 3.8 (br, s, 1H), 3.6
(m, 2H), 2.0 (m, 1H), 1.8–1.7 (m, 3H), 1.5 (t, 3H), 1.0
(s, 3H), 0.90 (s, 3H), 0.88 (s, 3H). 13C NMR (90 MHz,
CDCl3): l 3.9, 4.6, 5.3, 11.2, 27.9, 28.0, 29.2, 33.3, 34.6,
38.2, 48.6, 88.3, 92.0, 127.2, 128.2, 128.8, 129.8, 132.4,
184.2. ESI-MS calcd for C21H30NO3S (MH+): 376.1946;
found 376.1953. Anal. calcd for C21H29NO3S: C,
67.17%, H, 7.78%. Found: C, 67.32%, H, 7.94%.
7.3.2. (1R,2S,6R,7S)-1,10,10-Trimethyl-5-((1R)-2-oxo-2-
cyclohexyl-1-phenylsulfanyl-ethyl)-3-oxa-5-aza-tricyclo
[5.2.1.02,6]decane-4-one (from 9b/10b). Mp: 158–160°C;
IR (KBr): 3100, 3010, 2980, 1720, 1695, 1480, 1410,
1
1340, 1270, 1220, 1100, 1030, 970, 930, 820 cm−1. H
7.2.4.
(1R,2S,6R,7S)-5-((1R,2S)-2-Hydroxy-3,3-
NMR (400 MHz, CDCl3): l 7.6–7.2 (m, 5H), 3.8 (m,
1H), 3.7 (m, 2H), 2.2 (m, 2H), 1.8–1.6 (m, 3H), 1.3–0.92
(m, 11H), 1.0 (s, 3H), 0.90 (s, 3H), 0.88 (s, 3H). 13C
NMR (90 MHz, CDCl3): l 3.90, 4.2, 4.4, 4.8, 5.0, 5.2,
11.2, 27.9, 29.2, 33.3, 34.6, 38.2, 48.6, 88.3, 92.0, 127.2,
128.2, 129.8, 132.4, 178.4, 185.2. ESI-MS calcd for
C25H34NO3S (MH+): 428.2259; found 428.2271. Anal.
calcd for C25H33NO3S: C, 70.22%, H, 7.78%, N, 3.28%;
found: C, 70.53%, H, 8.08%, N, 3.14%.
dimethyl-1-phenylsulfanylbutyl)-1,10,10-trimethyl-3-oxo-
5-aza-tricyclo-[5.2.1.02,6]-decane-4-one 9c (from addition
of 3 to pivaldehyde). Mp: 135–136°C; IR: (br) 3450,
3010, 2990, 1700, 1490, 1410, 1340, 1270, 1220, 1100,
1
1030, 970, 930, 820 cm−1. H NMR (400 MHz, CDCl3):
l 7.6–7.2 (m, 5H), 4.2 (d, J=6 Hz, 1H), 4.0 (m, 1H),
3.7 (m, 2H), 3.2 (br, s, 1H), 1.8 (m, 2H), 1.7–1.6 (m,
3H), 1.1 (s, 3H), 0.90 (s, 3H), 0.80 (d, J=6 Hz, 9H),
0.76 (s, 3H). 13C NMR (90 MHz, CDCl3): l 3.98 (3C),
4.6, 5.3, 5.4, 11.2, 27.1, 28.3, 28.5, 29.2, 33.3, 34.6, 38.2,
48.6, 52.2, 88.3, 92.0, 127.8, 128.2, 128.8, 129.8, 185.2.
ESI-MS calcd for C25H34NO3S (MH+): 404.2259; found
404.2258. Anal. calcd for C23H33NO3S: C, 68.45%, H,
8.24%; found: C, 68.61%, H, 8.23%. Crystal data:
C23H33NO3S, M=403.6, orthorhombic, space group
7.3.3. (1R,2S,6R,7S)-1,10,10-Trimethyl-5-((1R)-2-oxo-
3,3-dimethyl-1-phenylsulfanyl-butyl)-3-oxa-5-aza-tricy-
clo-[5.2.1.02,6]-decane-4-one
(from
9c/10c).
Mp:
66–68°C; IR (KBr): 3010, 2990, 1700, 1690, 1490, 1410,
1
1340, 1270, 1220, 1100, 1030, 970, 930, 820 cm−1. H
,
P212121, a=6.8616(5), b=12.011(1), c=27.465(2) A,
V=2263.4(3) A , Z=4; Data were collected on a
NMR (400 MHz, CDCl3): l 7.6–7.2 (m, 5H), 4.0 (m,
1H), 3.7 (m, 2H), 1.8 (m, 2H), 1.7–1.6 (m, 3H), 1.1 (s,
3H), 0.90 (s, 3H), 0.80 (s, 9H), 0.76 (s, 3H). 13C NMR
(90 MHz, CDCl3): l, 3.98 (3C), 4.6, 5.2, 5.7, 11.2, 28.0,
29.2, 33.3, 34.6, 38.2, 48.6, 88.2, 127.8, 128.2, 128.8,
129.8, 132.4, 178.8, 185.2. Anal. calcd for C23H31NO3S:
C, 68.79%, H, 7.78%. Found: C, 68.94%, H, 7.91%.
3
,
Bruker SMART1000 CCD diffractometer at 27°C with
MoKa radiation (u=0.71073 A). R1=0.0325, wR2=
0.0727, absolute structure (Flack) parameter=−0.04(6).
Further details have been deposited with the Cam-
bridge Crystallographic Data Centre (CCDC 175201,
UM169).
,
7.3.4. (1R,2S,6R,7S)-1,10,10-Trimethyl-5-((1R)-2-oxo-1-
phenylsulfanyl-butyl)-3-oxa-5-aza-tricyclo-[5.2.1.02,6]-
decane-4-one (from 9d/10d). Mp: 82°–84°C; IR (KBr):
3010, 2990, 1710, 1690, 1490, 1410, 1360, 1340, 1270,
7.3. General procedure for the oxidation of carbinol
products 9/10 with pyridinium chlorochromate (PCC)
To a stirred suspension of pyridinium chlorochromate
(23.3 g, 0.15 mol) in anhydrous dichloromethane (150
mL) at 25°C was added the corresponding carbinols
9/10 (0.1 mol) dissolved in dichloromethane (20 mL) in
one portion. After stirring the mixture for 1.5 h, dry
diethyl ether (200 mL) was added and the supernatant
liquid decanted from a black gum. The insoluble
residue was washed with ether (3×30 mL) until it
became a granular black solid. The combined ether
solution was passed through a short pad of florisil
under vacuum. The solvent was removed by rotary
evaporation, affording the ketone product in 85–95%
yield. The ketones were purified by recrystallization
(diethyl ether/hexane, 3:2) for characterization.
1
1220, 1100, 1030, 970, 930, 820 cm−1. H NMR (400
MHz, CDCl3): l 7.6–7.2 (m, 5H), 4.1 (m, 1H), 3.9 (q,
2H), 3.6 (m, 2H), 2.0 (m, 2H), 1.8–1.7 (m, 3H), 1.4 (t,
3H), 1.0 (s, 3H), 0.90 (s, 3H), 0.88 (s, 3H). 13C NMR
(90 MHz, CDCl3): l 3.9, 4.6, 5.3, 5.7, 11.2, 28.0, 29.2,
33.2, 34.6, 38.2, 48.6, 88.2, 92.0, 128.8, 129.8, 132.4,
134.8, 180.2, 184.2. ESI-MS calcd for C21H28NO3S
374.1790 (MH+): found 374.1785. Anal. calcd for
C21H27NO3S: C, 67.53%, H, 7.29%. Found: C, 67.90%,
H, 7.54%.
7.4. General procedure for the reduction of above
ketones to 9/10 epimeric carbinol mixture with sodium
borohydride
7.3.1. (1R,2S,6R,7S)-1,10,10-Trimethyl-5-((1R)-2-oxo-
2-phenyl-1-phenylsulfanyl-ethyl)-3-oxa-5-aza-tricyclo-
[5.2.1.02,6]-decane-4-one (from 9a/10a). Mp: 96–98°C;
IR (KBr): 3020, 2980, 1950, 1720, 1695, 1590, 1410,
To a stirred solution of the ketone (1 mmol) in
methanol (15 mL) at 25°C was added a solution of
NaBH4 (2 mmol) in water/methanol (1:1 v/v) in one